The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Angelo Antonini

Department for Parkinson Disease

IRCCS San Camillo

Venice

Italy

[email]@yahoo.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department for Parkinson Disease, IRCCS San Camillo, Venice, Italy. 2010 - 2011
  • IRRCS, San Camillo, Viale Alberoni 70, Venice, Italy. 2010
  • Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy. 2006 - 2009
  • Parkinson Institute, Milan, Italy. 2008

References

  1. Pharmacokinetic evaluation of pramipexole. Antonini, A., Calandrella, D. Expert. Opin. Drug. Metab. Toxicol (2011) [Pubmed]
  2. Role of pramipexole in the management of Parkinson's disease. Antonini, A., Barone, P., Ceravolo, R., Fabbrini, G., Tinazzi, M., Abbruzzese, G. CNS. Drugs (2010) [Pubmed]
  3. Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders. Antonini, A., Bernardi, L., Calandrella, D., Mancini, F., Plebani, M. Funct. Neurol. (2010) [Pubmed]
  4. Continuous dopaminergic delivery in Parkinson's disease. Antonini, A., Ursino, G., Calandrella, D., Bernardi, L., Plebani, M. J. Neurol. (2010) [Pubmed]
  5. Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease. Antonini, A., Chaudhuri, K.R., Martinez-Martin, P., Odin, P. CNS. Drugs (2010) [Pubmed]
  6. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Antonini, A., Cilia, R. Drug. Saf (2009) [Pubmed]
  7. Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease. Antonini, A., Odin, P. Parkinsonism Relat. Disord. (2009) [Pubmed]
  8. Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management. Antonini, A., Tolosa, E. Expert. Rev. Neurother (2009) [Pubmed]
  9. The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson's disease. Antonini, A., Mirò, L., Castiglioni, C., Pezzoli, G. Neurol. Sci. (2008) [Pubmed]
  10. Dopamine agonist-based strategies in the treatment of Parkinson's disease. Antonini, A., Barone, P. Neurol. Sci. (2008) [Pubmed]
  11. Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Antonini, A., Berto, P., Lopatriello, S., Tamma, F., Annemans, L., Chambers, M. Mov. Disord. (2008) [Pubmed]
  12. COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features. Antonini, A., Abbruzzese, G., Barone, P., Bonuccelli, U., Lopiano, L., Onofrj, M., Zappia, M., Quattrone, A. Neuropsychiatr. Dis. Treat (2008) [Pubmed]
  13. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini, A., Mancini, F., Canesi, M., Zangaglia, R., Isaias, I.U., Manfredi, L., Pacchetti, C., Zibetti, M., Natuzzi, F., Lopiano, L., Nappi, G., Pezzoli, G. Neurodegener. Dis (2008) [Pubmed]
  14. Single photon-emission computed tomography imaging in early Parkinson's disease. Antonini, A., Isaias, I.U. Expert. Rev. Neurother (2008) [Pubmed]
  15. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Antonini, A., Poewe, W. Lancet. Neurol (2007) [Pubmed]
  16. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Antonini, A., Isaias, I.U., Canesi, M., Zibetti, M., Mancini, F., Manfredi, L., Dal Fante, M., Lopiano, L., Pezzoli, G. Mov. Disord. (2007) [Pubmed]
  17. New strategies in motor parkinsonism. Antonini, A. Parkinsonism Relat. Disord. (2007) [Pubmed]
  18. The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies. Antonini, A. Neuropsychiatr. Dis. Treat (2007) [Pubmed]
  19. Continuous dopaminergic stimulation--from theory to clinical practice. Antonini, A. Parkinsonism Relat. Disord. (2007) [Pubmed]
  20. Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration. Antonini, A., Goldwurm, S., Benti, R., Prokisch, H., Ebhardt, M., Cilia, R., Zini, M., Righini, A., Cossu, G., Pezzoli, G. Mov. Disord. (2006) [Pubmed]
 
WikiGenes - Universities